|
ZNF16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.36800000052995E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7661999995866E-07 |
| Normal-vs-Stage2 |
2.627300E-04 |
| Normal-vs-Stage3 |
1.290760E-01 |
| Normal-vs-Stage4 |
3.699400E-01 |
| Stage1-vs-Stage2 |
9.573600E-01 |
| Stage1-vs-Stage3 |
7.139500E-02 |
| Stage1-vs-Stage4 |
2.557200E-01 |
| Stage2-vs-Stage3 |
1.695990E-01 |
| Stage2-vs-Stage4 |
3.021200E-01 |
| Stage3-vs-Stage4 |
9.762400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60090000034252E-07 |
| Normal-vs-AfricanAmerican |
4.434800E-04 |
| Normal-vs-Asian |
5.872400E-01 |
| Caucasian-vs-AfricanAmerican |
4.663400E-01 |
| Caucasian-vs-Asian |
3.391400E-01 |
| AfricanAmerican-vs-Asian |
5.053200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.01319999957062E-08 |
| Normal-vs-Female |
2.402000E-03 |
| Male-vs-Female |
9.599700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.622500E-03 |
| Normal-vs-Extreme_Weight |
9.73050000019349E-07 |
| Normal-vs-Obese |
1.856400E-03 |
| Normal-vs-Extreme_Obese |
4.317700E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.026200E-01 |
| Normal_Weight-vs-Obese |
9.440200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.690610E-01 |
| Extreme_Weight-vs-Obese |
2.147400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.235000E-01 |
| Obese-vs-Extreme_Obese |
1.342970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.320000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.404600E-04 |
| Normal-vs-Age(61-80Yrs) |
8.39040004141367E-09 |
| Normal-vs-Age(81-100Yrs) |
2.228000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.689400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.621400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.491600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.937600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.427800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.998400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.85670000041327E-07 |
| Normal-VS-Type2 PRCC |
5.35079999974819E-07 |
| Normal-VS-KIRP CIMP |
3.079600E-02 |
| Normal-VS-Unclassified PRCC |
2.256100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.314800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.032800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.564600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.556400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.447600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.674200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46619999999531E-06 |
| Normal-vs-N1 |
3.240000E-01 |
| Normal-vs-N2 |
9.479200E-01 |
| N0-vs-N1 |
3.056500E-02 |
| N0-vs-N2 |
1.052360E-01 |
| N1-vs-N2 |
7.041800E-01 |
|
|
